A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: healthier (42), improved (762)

Fulvestrant-Palbociclib

Description
Chemotherapy Protocol Breast Cancer Fulvestrant-Palbociclib Regimen • Breast Cancer – Fulvestrant-Palbociclib Indication Palboci
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Fulvestrant-Palbociclib.pdf

Exemestane-Ribociclib

Description
Chemotherapy Protocol Breast Cancer Exemestane-Ribociclib Regimen • Breast Cancer – Exemestane-Ribociclib Indication • Ribociclib in c
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Exemestane-Ribociclib.pdf

Cyclophosphamide-Doxorubicin-Paclitaxel

Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOXORUBICIN-PACLITAXEL (21 day) Regimen • Breast Cancer – Cyclophosphamide-Doxorubicin-Paclitaxel (21 day) Indication • Neoadjuvant / adjuvant therapy
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Doxorubicin-Paclitaxel.pdf

Capecitabine-Lapatinib

Description
Chemotherapy Protocol BREAST CANCER CAPECITABINE-LAPATINIB This protocol may require funding Regimen • Breast Cancer – Capecitabine-Lapatinib Indication • Treatment of locally advanced
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/CapecitabineLapatinib.pdf

Prostate artery embolisation - patient information

Description
This factsheet explains what is involved in having a prostate artery embolisation (PAE) and outlines the possible risks.
Url
/Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Prostate-artery-embolisation-2244-PIL.pdf

Azacitidine5

Description
Chemotherapy Protocol Myelodysplastic Syndrome (MDS) Acute Myeloid Leukaemia (AML) Chronic Myelomonocytic Leukaemia (CMML) Azacitidine SC (5 days) This is an unlicensed
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Azacitidine5.pdf

Azacitidine5+2Ver1

Description
Chemotherapy Protocol Myelodysplastic Syndrome (MDS) Acute Myeloid Leukaemia (AML) Chronic Myelomonocytic Leukaemia (CMML) Azacitidine SC (5+2 days) This is not
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Azacitidine5-2Ver1.pdf

Niraparib

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCERS Regimen NIRAPARIB • Ovarian Cancer – Niraparib Indication • Niraparib is recommended as maintenance treatment in patients with relapsed, platinum
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Niraparib.pdf

Capecitabine-Cisplatin

Description
Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER CAPECITABINE and CISPLATIN Regimen • Gastrointestinal Cancer (upper) – Capecitabine and Cisplatin Indication • First line therapy of inoperable
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Capecitabine-Cisplatin.pdf

Fluorouracil-Folinic Acid-Irinotecan-Oxaliplatin

Description
Chemotherapy Protocol PANCREATIC CANCER FLUOROURACIL-FOLINIC ACID-IRINOTECAN-OXALIPLATIN (FOLFIRINOX) This protocol may require funding Regimen • Pan
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Pancreas/Fluorouracil-Folinic-Acid-Irinotecan-Oxaliplatin.pdf
371 to 380 of 455
Previous … 36 37 38 39 40 … Next